<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38114867</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>06</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1865-8652</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Advances in therapy</Title><ISOAbbreviation>Adv Ther</ISOAbbreviation></Journal><ArticleTitle>Impact of Elevated Body Mass Index (BMI) on Hedonic Tone in Persons with Post-COVID-19 Condition: A Secondary Analysis.</ArticleTitle><Pagination><StartPage>686</StartPage><EndPage>695</EndPage><MedlinePgn>686-695</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12325-023-02760-2</ELocationID><Abstract><AbstractText Label="INTRODUCTION">The post-COVID-19 condition (PCC) is characterized by persistent, distressing symptoms following an acute COVID-19 infection. These symptoms encompass various domains, including hedonic tone, which is critical for overall well-being. Furthermore, obesity is both a risk factor for COVID-19 and PCC and associated with impaired hedonic tone. This study aims to investigate whether elevated body mass index (BMI) is associated with hedonic tone in persons with PCC.</AbstractText><AbstractText Label="METHODS">We perform a post hoc analysis of a randomized, double-blind, placebo-controlled clinical trial investigating the impact of vortioxetine on cognitive impairment in persons with PCC. Statistical analysis of baseline data using a generalized linear model was undertaken to determine the relationship of BMI to hedonic tone measured by Snaith-Hamilton Pleasure Scale (SHAPS) scores. The model was adjusted for covariates including age, sex, race, suspected versus confirmed COVID-19 cases, alcohol amount consumed per week, and annual household income.</AbstractText><AbstractText Label="RESULTS">The baseline data of 147 participants were available for analysis. BMI had a statistically significant positive association with baseline SHAPS total scores (&#x3b2;&#x2009;=&#x2009;0.003, 95% CI [6.251E-5, 0.006], p&#x2009;=&#x2009;0.045), indicating elevated BMI is associated with deficits in self-reported reward system functioning.</AbstractText><AbstractText Label="CONCLUSION">Higher BMI is associated with greater deficits in hedonic tone in persons with PCC, which may impact reward functioning processes such as reward prediction and processing. The mediatory effect of BMI on reward function underscores the need to investigate the neurobiologic interactions to elucidate preventative and therapeutic interventions for persons with PCC. Therapeutic development targeting debilitating features of PCC (e.g., motivation, cognitive dysfunction) could consider stratification on the basis of baseline BMI.</AbstractText><AbstractText Label="TRIAL REGISTRATION NUMBER">NCT05047952.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Healthcare Ltd., part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Le</LastName><ForeName>Gia Han</ForeName><Initials>GH</Initials><AffiliationInfo><Affiliation>Brain and Cognition Discovery Foundation, 77 Bloor Street West, Suite 617, Toronto, ON, M5S 1M2, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Science, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwan</LastName><ForeName>Angela T H</ForeName><Initials>ATH</Initials><AffiliationInfo><Affiliation>Brain and Cognition Discovery Foundation, 77 Bloor Street West, Suite 617, Toronto, ON, M5S 1M2, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Brain and Cognition Discovery Foundation, 77 Bloor Street West, Suite 617, Toronto, ON, M5S 1M2, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Ziji</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Brain and Cognition Discovery Foundation, 77 Bloor Street West, Suite 617, Toronto, ON, M5S 1M2, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teopiz</LastName><ForeName>Kayla M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Brain and Cognition Discovery Foundation, 77 Bloor Street West, Suite 617, Toronto, ON, M5S 1M2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badulescu</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Brain and Cognition Discovery Foundation, 77 Bloor Street West, Suite 617, Toronto, ON, M5S 1M2, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Science, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meshkat</LastName><ForeName>Shakila</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Brain and Cognition Discovery Foundation, 77 Bloor Street West, Suite 617, Toronto, ON, M5S 1M2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>d'Andrea</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Imaging and Clinical Sciences, "G. d'Annunzio" University, Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Roger</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Health Innovation and Technology (iHealthtech), National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rhee</LastName><ForeName>Taeho Greg</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health Sciences, University of Connecticut School of Medicine, Farmington, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Bing</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Key Laboratory of Cognition and Personality, Faculty of Psychology, Ministry of Education, Southwest University, Chongqing, 400715, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phan</LastName><ForeName>Lee</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Brain and Cognition Discovery Foundation, 77 Bloor Street West, Suite 617, Toronto, ON, M5S 1M2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosenblat</LastName><ForeName>Joshua D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Institute of Medical Science, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mansur</LastName><ForeName>Rodrigo B</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>Brain and Cognition Discovery Foundation, 77 Bloor Street West, Suite 617, Toronto, ON, M5S 1M2, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Science, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subramaniapillai</LastName><ForeName>Mehala</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Brain and Cognition Discovery Foundation, 77 Bloor Street West, Suite 617, Toronto, ON, M5S 1M2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McIntyre</LastName><ForeName>Roger S</ForeName><Initials>RS</Initials><Identifier Source="ORCID">0000-0003-4733-2523</Identifier><AffiliationInfo><Affiliation>Brain and Cognition Discovery Foundation, 77 Bloor Street West, Suite 617, Toronto, ON, M5S 1M2, Canada. roger.mcintyre@bcdf.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada. roger.mcintyre@bcdf.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University of Toronto, Toronto, ON, Canada. roger.mcintyre@bcdf.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05047952</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Adv Ther</MedlineTA><NlmUniqueID>8611864</NlmUniqueID><ISSNLinking>0741-238X</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057181" MajorTopicYN="N">Pleasure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BMI</Keyword><Keyword MajorTopicYN="N">Hedonic tone</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">PCC</Keyword><Keyword MajorTopicYN="N">Post-COVID condition</Keyword><Keyword MajorTopicYN="N">Post-COVID-19</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>20</Day><Hour>0</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38114867</ArticleId><ArticleId IdType="doi">10.1007/s12325-023-02760-2</ArticleId><ArticleId IdType="pii">10.1007/s12325-023-02760-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. WHO coronavirus (COVID-19) dashboard [Internet]. WHO; 2023.</Citation></Reference><Reference><Citation>Vimercati L, de Maria L, Quarato M, et al. Association between long COVID and Overweight/Obesity. J Clin Med. 2021;10(18):4143. https://doi.org/10.3390/jcm10184143 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10184143</ArticleId><ArticleId IdType="pubmed">34575251</ArticleId><ArticleId IdType="pmc">8469321</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn KL, Katz GM, Bobos P, et al. Understanding the post COVID-19 condition (long COVID) in adults and the expected burden for Ontario. Ont COVID-19 Sci Advis Table. 2022. https://doi.org/10.47326/ocsat.2022.03.65.1.0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.47326/ocsat.2022.03.65.1.0</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2013;7. https://doi.org/10.1016/S1473-3099(21)00703-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;31. https://doi.org/10.1038/s41591-021-01292-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId><ArticleId IdType="pmc">7611399</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechner-Scott J, Levy M, Hawkes C, et al. Long covid or post covid-19 syndrome. Mult Scler Relat Disord. 2021;55: 103268. https://doi.org/10.1016/j.msard.2021.103268 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2021.103268</ArticleId><ArticleId IdType="pubmed">34601388</ArticleId><ArticleId IdType="pmc">8447548</ArticleId></ArticleIdList></Reference><Reference><Citation>Visco V, Vitale C, Antonella R, et al. Post-COVID-19 syndrome: involvement and interactions between respiratory, cardiovascular and nervous systems. J Clin Med. 2022;11(3):524. https://doi.org/10.3390/jcm11030524 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11030524</ArticleId><ArticleId IdType="pubmed">35159974</ArticleId><ArticleId IdType="pmc">8836767</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R, et al. Risk factors associated with post-COVID-19 condition: a systematic review and meta-analysis. JAMA Intern Med. 2023;183(6):566&#x2013;80. https://doi.org/10.1001/jamainternmed.2023.0750 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId><ArticleId IdType="pmc">10037203</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan RM, Huta V, Deci EL. Living well: a self-determination theory perspective on eudaimonia. J Happiness Stud. 2008;9:139&#x2013;70. https://doi.org/10.1007/s10902-006-9023-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10902-006-9023-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamontagne SJ, Winters MF, Pizzagalli DA, Olmstead MC. Post-acute sequelae of COVID-19: evidence of mood and cognitive impairment. Brain Behav Immun Health. 2021;17: 100347. https://doi.org/10.1016/j.bbih.2021.100347 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100347</ArticleId><ArticleId IdType="pubmed">34549199</ArticleId><ArticleId IdType="pmc">8437695</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, Poletti S, Benedetti F. Post-COVID-19 depressive symptoms: epidemiology, pathophysiology, and pharmacological treatment. CNS Drugs. 2022;36(7):681&#x2013;702. https://doi.org/10.1007/s40263-022-00931-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40263-022-00931-3</ArticleId><ArticleId IdType="pubmed">35727534</ArticleId><ArticleId IdType="pmc">9210800</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho J, Goldenson NI, Pester MS, et al. Longitudinal associations between anhedonia and BMI trajectory groups among adolescents. J Adolesc Health. 2018;63(1):81&#x2013;7. https://doi.org/10.1016/j.jadohealth.2017.12.022 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jadohealth.2017.12.022</ArticleId><ArticleId IdType="pubmed">29731318</ArticleId><ArticleId IdType="pmc">6067955</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes S, Rimkus CDM, Lozoff B, et al. Assessing cognitive control and the reward system in overweight young adults using sensitivity to incentives and white matter integrity. PLoS ONE. 2020;15(6):e0233915. https://doi.org/10.1371/journal.pone.0233915 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0233915</ArticleId><ArticleId IdType="pubmed">32484819</ArticleId><ArticleId IdType="pmc">7266313</ArticleId></ArticleIdList></Reference><Reference><Citation>He R, Zheng R, Zheng J, et al. Causal association between obesity, circulating glutamine levels, and depression: a mendelian randomization study. J Clin Endocrinol Metab. 2023;108(6):1432&#x2013;41. https://doi.org/10.1210/clinem/dgac707 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgac707</ArticleId><ArticleId IdType="pubmed">36510667</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R, Rathore SS, Khan H, et al. Association of obesity with COVID-19 severity and mortality: an updated systemic review, meta-aanalysis, and meta-regression. Front Endocrinol. 2022;13: 780872. https://doi.org/10.3389/fendo.2022.780872 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.780872</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides TC, Steward JM, Hatziagelaki E, et al. Brain &#x201c;fog&#x201d;, inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin. Front Neurosci. 2015;9:225. https://doi.org/10.3389/fnins.2015.00225 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2015.00225</ArticleId><ArticleId IdType="pubmed">26190965</ArticleId><ArticleId IdType="pmc">4490655</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Nicola M, Pepe M, Montanari S, et al. Vortioxetine improves physical and cognitive symptoms in patients with post-COVID-19 major depressive episodes. Eur Neuropsychopharmacol. 2023;70:21&#x2013;8. https://doi.org/10.1016/j.euroneuro.2023.02.006 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2023.02.006</ArticleId><ArticleId IdType="pubmed">36808043</ArticleId><ArticleId IdType="pmc">9905099</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain and Cognition Discovery Foundation. Randomized, Double-Blinded, Placebo-Controlled Clinical Trial Evaluating Vortioxetine for Cognitive Deficits in Persons with Post-COVID-19 Condition. ClinicalTrials.gov identifier: NCT05047952. 2022. https://clinicaltrials.gov/ct2/show/NCT05047952 . Accessed 05 April 2023.</Citation></Reference><Reference><Citation>McIntyre RS, Phan L, Kwan ATH, et al. Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial. Brain. 2023. https://doi.org/10.1093/brain/awad377 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awad377</ArticleId><ArticleId IdType="pubmed">37936330</ArticleId></ArticleIdList></Reference><Reference><Citation>International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). Integrated Addendum to ICH E6(R1): Guideline for Good Clinical Practice. 2016. https://database.ich.org/ . Accessed 25 Sep 2023.</Citation></Reference><Reference><Citation>WMA: The World Medical Association-Declaration of Helsinki. 2008. https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/doh-oct2008/ . Accessed 25 Sep 2023.</Citation></Reference><Reference><Citation>Snaith RP, Hamilton M, Morley S, et al. A scale for the assessment of hedonic tone the Snaith-Hamilton pleasure scale. Br J Psychiatry. 1995;167(1):99&#x2013;103. https://doi.org/10.1192/bjp.167.1.99 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.167.1.99</ArticleId><ArticleId IdType="pubmed">7551619</ArticleId></ArticleIdList></Reference><Reference><Citation>Defining Adult Overweight and Obesity [Internet]. Centers for Disease Control and Prevention. 2023. https://www.cdc.gov/obesity/basics/adult-defining.html . Accessed 01 April 2023.</Citation></Reference><Reference><Citation>Snaith-Hamilton pleasure scale [Internet]. 2023. https://datashare.nida.nih.gov/instrument/snaith-hamilton-pleasure-scale . Accessed 20 Nov 2023.</Citation></Reference><Reference><Citation>Ribeiro G, Camacho M, Santos O, et al. Association between hedonic hunger and body-mass index versus obesity status. Sci Rep. 2018;8:5857. https://doi.org/10.1038/s41598-018-23988-x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-23988-x</ArticleId><ArticleId IdType="pubmed">29643337</ArticleId><ArticleId IdType="pmc">5895788</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill H, Gill B, Lipsitz O, et al. The impact of overweight/obesity on monetary reward processing: a systematic review. J Psychiatr Res. 2021;137:456&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2021.03.029</ArticleId><ArticleId IdType="pubmed">33798972</ArticleId></ArticleIdList></Reference><Reference><Citation>Volkow ND, Wang GJ, Baler RD. Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn Sci. 2011;15(1):37&#x2013;46. https://doi.org/10.1016/j.tics.2010.11.001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tics.2010.11.001</ArticleId><ArticleId IdType="pubmed">21109477</ArticleId></ArticleIdList></Reference><Reference><Citation>Meemken MT, Kube J, Wickner C, Horstmann A. Keeping track of promised rewards: Obesity predicts enhanced flexibility when learning from observation. Appetite. 2018;131:117&#x2013;24. https://doi.org/10.1016/j.appet.2018.08.029 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.appet.2018.08.029</ArticleId><ArticleId IdType="pubmed">30170021</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansur RB, Subramaniapillai M, Zuckerman H, et al. Effort-based decision-making is affected by overweight/obesity in major depressive disorder. J Affect Disord. 2019;256:221&#x2013;7. https://doi.org/10.1016/j.jad.2019.06.002 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2019.06.002</ArticleId><ArticleId IdType="pubmed">31181378</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez LR, Rasmussen EB, Kyne-Rucker D, et al. Delay discounting and obesity in food insecure and food secure women. Health Psychol. 2021;40(4):242&#x2013;51. https://doi.org/10.1037/hea0001042 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/hea0001042</ArticleId><ArticleId IdType="pubmed">33856831</ArticleId><ArticleId IdType="pmc">8362266</ArticleId></ArticleIdList></Reference><Reference><Citation>Barlow P, Reeves A, McKee M, et al. Unhealthy diets, obesity and time discounting: a systematic literature review and network analysis. Obes Rev. 2016;17(9):810&#x2013;9. https://doi.org/10.1111/obr.12431 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/obr.12431</ArticleId><ArticleId IdType="pubmed">27256685</ArticleId><ArticleId IdType="pmc">4988386</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang J, Chrzanowski-Smith OJ, Hutchinson G, et al. Relationship between monetary delay discounting and obesity: a systematic review and meta-regression. Int J Obes. 2019;43(6):1135&#x2013;46. https://doi.org/10.1038/s41366-018-0265-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41366-018-0265-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, et al. Fatigue and cognitive impairment in Post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun. 2022;101:93&#x2013;135. https://doi.org/10.1016/j.bbi.2021.12.020 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenman R, Tennekoon V, Hill LG. Measuring bias in self-reported data. Int J Behav Healthc Res. 2011;2(4):320&#x2013;32. https://doi.org/10.1504/IJBHR.2011.043414 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1504/IJBHR.2011.043414</ArticleId><ArticleId IdType="pubmed">25383095</ArticleId><ArticleId IdType="pmc">4224297</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>